| December 1, 2022 | | | 取締役会命令 | |
| | | |
/s/ Joel Shulman
Joel Shulman
会長兼CEO |
|
| December 1, 2022 | | | 取締役会命令 | |
| | | |
/s/ Joel Shulman
Joel Shulman
会長兼CEO |
|
| | |
Page
|
| |||
会議に関する対話
|
| | | | 1 | | |
前向き陳述
|
| | | | 12 | | |
RISK FACTORS
|
| | | | 13 | | |
BACKGROUND
|
| | | | 16 | | |
THE MEETING
|
| | | | 17 | | |
提案一-延期修正案提案
|
| | | | 20 | | |
提案二-役員選挙提案
|
| | | | 26 | | |
提案三-休会提案
|
| | | | 27 | | |
アメリカ連邦所得税の考慮事項
|
| | | | 28 | | |
取締役、役員、会社管理
|
| | | | 32 | | |
ある関係と関連先取引
|
| | | | 40 | | |
証券の実益所有権
|
| | | | 42 | | |
株主提案
|
| | | | 44 | | |
家屋預かり情報
|
| | | | 44 | | |
どこでもっと情報を見つけることができますか
|
| | | | 44 | | |
添付ファイルA-ApeIron資本投資会社の登録証明書の改正と再記載の修正案。
|
| | | | A-1 | | |
Name
|
| |
Age
|
| |
Position
|
|
Dr. Joel Shulman | | |
55
|
| | 会長兼CEO | |
Eva Adosoglou | | |
31
|
| | 首席運営官 | |
Grant Grigorian | | |
59
|
| | 首席財務官 | |
Kevin Cramton | | |
61
|
| | Director | |
Charles Aggouras | | |
55
|
| | Director | |
Jeffrey Mortimer | | |
57
|
| | Director | |
| | |
Class A Common Stock
|
| |
Class B Common Stock
|
| |
Approximate
Percentage of Outstanding Common Stock |
| |||||||||||||||||||||
受益者名と住所(1)
|
| |
Number of
Shares Beneficially Owned |
| |
Approximate
Percentage of Class |
| |
Number of
Shares Beneficially Owned |
| |
Approximate
Percentage of Class |
| ||||||||||||||||||
ApeIron Capitalスポンサー,LLC(2)
|
| | | | — | | | | | | — | | | | | | 4,312,500 | | | | | | 100% | | | | | | 20% | | |
Joel Shulman(3)
|
| | | | — | | | | | | — | | | | | | 4,312,500 | | | | | | 100% | | | | | | 20% | | |
Eva Adosoglou(3)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Grant Grigorian(3)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Kevin Cramton(3)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Charles Aggouras(3)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Jeffrey Mortimer(3)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
すべての役員と取締役を1つのグループとして
(six individuals) |
| | | | — | | | | | | — | | | | | | 4,312,500 | | | | | | 100% | | | | | | 20% | | |
Other 5% Stockholders | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Highbridge Capital Management,LLC(4)
|
| | | | 1,179,474 | | | | | | 6.84% | | | | | | — | | | | | | — | | | | | | 5.5% | | |
カラモス市場中性収益基金(5)
|
| | | | 1,000,000 | | | | | | 5.8% | | | | | | — | | | | | | — | | | | | | 4.6% | | |
Saba Capital Management L.P.(6)
|
| | | | 1,300,000 | | | | | | 7.5% | | | | | | — | | | | | | — | | | | | | 6.0% | | |
| | | | ApeIron資本投資会社 | |
| | | |
By:
|
|
| | | | Name: Dr. Joel Shulman | |
| | | | 職務:CEO | |